Ophthalmology Solution Articles & Analysis
5 news found
STEMart, a US-based provider of comprehensive services for all phases of medical device development, is proud to announce the launch of its new Particulate Matter Testing Services, offering a wide range of particulate testing from <0.001 μm to >3,000 μm. STEMart can provide accurate analysis and material characterization from nanometer scale particles to bulk powders with its various ...
BySTEMart
The safety of a medicine is of vital importance to the safety of patients. Many factors may affect drug safety during pharmaceutical manufacturing. As a New York-based CRO company, CD Formulation always gives high priority to drug safety issues and recently announced its capability of performing particulate matter testing in compliance with relevant regulations, in particular USP <788>. ...
Approximately 70% of Subjects were Well-Controlled on iDose TR with the Same or Fewer Topical IOP-Lowering Medications at 36 Months vs. Screening Favorable Safety Profile Through 36 Months . SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the iPRIME™ Viscodelivery System, a sterile, ...
Additional awards and recognition include: President and CEO Dave Van Meter named Entrepreneur Of The Year® by Ernst & Young LLP (2020 Pacific Southwest-Orange County division) “Strong Recommendation” of Ivantis’ Hydrus Microstent under the American Academy of Ophthalmology’s (AAO) 2020 Primary Open-Angle Glaucoma Preferred Practice Pattern; ...